You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Receptors, GABA-A

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Parkinson Disease Trial in Ann Arbor (Flumazenil, Placebo)

Completed
Has Results
  • Parkinson Disease
  • Ann Arbor, Michigan
    University of Michigan Functional Neuroimaging, Cognitive and Mo
Jun 4, 2022

Parkinson Disease Trial in Ann Arbor (Clarithromycin (Not used as of 4/2020), Placebo (Not used as of 4/2020), Transdermal

Completed
  • Parkinson Disease
  • Clarithromycin (Not used as of 4/2020)
  • +3 more
  • Ann Arbor, Michigan
    University of Michigan Health System Functional Neuroimaging, Co
Mar 22, 2022

GABA Biomarkers in Dravet Syndrome

Recruiting
  • Dravet Syndrome
  • GABA Blood Level
  • Fort Worth, Texas
    Cook Children's Medical Center
Dec 13, 2022

No Condition Trial in Manchester (Ketoprofen Lysine Salt combined with Gabapentin, Ketoprofen Lysine Salt, Gabapentin)

Completed
  • No Condition
  • Ketoprofen Lysine Salt combined with Gabapentin
  • +3 more
  • Manchester, United Kingdom
    MAC Clinical Research Early Phase Unit
May 19, 2022

Atypical Antipsychotics inGeriatric Population: What is Role of

Recruiting
  • Neutropenia
    • Strasbourg, France
      Service de Pharmacie - Stérilisation - CHU de Strasbourg - Franc
    Oct 27, 2023

    Prediabetes, Hypertension Trial in Wageningen (GABA, Placebo)

    Completed
    • Prediabetes
    • Hypertension
    • GABA
    • Placebo
    • Wageningen, Netherlands
      Wageningen University, Division of Human Nutrition
    Nov 15, 2021

    Cyclin-dependent Kinase Inhibitor 2A on Labor-related Signals

    Not yet recruiting
    • Preterm Labor
      • (no location specified)
      May 9, 2023

      Complement C5a Receptors in Hidradenitis Suppurativa

      Recruiting
      • Hidradenitis Suppurativa
        • Redwood City, California
          Stanford University
        Jun 27, 2022

        Opioid Use Disorder Trial (CVL-354, [11C]-LY2795050, [11C]-carfentanil)

        Not yet recruiting
        • Opioid Use Disorder
        • New Haven, Connecticut
          New Haven, Connecticut
        Jan 18, 2023

        Bipolar Disorder, Cannabis Use, Schizoaffective Disorder, Bipolar Type Trial in Charleston (Gabapentin, Placebo)

        Recruiting
        • Bipolar Disorder
        • +7 more
        • Charleston, South Carolina
          Medical University Of South Carolina
        Jul 6, 2022

        Venous Ulcer, Sickle Cell Ulcer, Diabetic Ulcer Trial in Paris (Saliva sampling, Blood sampling, Interviews)

        Not yet recruiting
        • Venous Ulcer
        • +3 more
        • Saliva sampling
        • +3 more
        • Paris, Ile De France, France
          Dermatology unit - Cochin Hospital - APHP
        Sep 8, 2023

        LILRA3 in Ankylosing Spondylitis and Axial Psoriatic Patients

        Not yet recruiting
        • Autoimmune Diseases
        • Leukocyte Immunoglobulin-like receptors A3
        • (no location specified)
        Jun 14, 2023

        Type 1 Diabetes Trial in Uppsala (Gamma-Aminobutyric Acid (GABA), Alprazolam)

        Recruiting
        • Type 1 Diabetes Mellitus
        • Uppsala, Sweden
          Uppsala University Hospital
        Sep 20, 2021

        Sleep Disturbance Trial in Seoul (GABA, Placebo)

        Completed
        • Sleep Disturbance
        • GABA
        • Placebo
        • Seoul, Korea, Republic of
          Kyunghee University Hospital at Gangdong
        Sep 17, 2021

        Fragile X Syndrome (FXS) Trial in Stanford (18F-FTC-146)

        Withdrawn
        • Fragile X Syndrome (FXS)
        • Stanford, California
          Stanford University
        Nov 10, 2022

        Schizophrenia Trial in Boston (CVL-231)

        Recruiting
        • Schizophrenia
        • Boston, Massachusetts
          Massachusetts General Hospital Translational and Clinical Resear
        Jul 6, 2022

        Neuroblastoma Trial in Lille, Lyon, Toulouse (PRRT with 177Lu-DOTATATE)

        Not yet recruiting
        • Neuroblastoma
        • PRRT with 177Lu-DOTATATE
        • Lille, France
        • +2 more
        Nov 8, 2022

        Acute Lymphoblastic Leukemia in Remission Trial in Suzhou (CD19 CAR-T cells and CD19 positive feeder T cells)

        Recruiting
        • Acute Lymphoblastic Leukemia in Remission
        • CD19 CAR-T cells and CD19 positive feeder T cells
        • Suzhou, Jiangsu, China
        • +2 more
        May 18, 2022

        Sleep Disorder Trial in Shanghai (Drinks with active ingredients such as poria and GABA)

        Completed
        • Sleep Disorder
        • Drinks with active ingredients such as poria and GABA
        • Shanghai, Shanghai, China
          Shanghai China-norm Quality Technical Service Co ，Ltd
        Jun 8, 2023

        Lung Cancer Circulating Tumor Cells

        Not yet recruiting
        • Non Small Cell Lung Cancer
        • Sample
        • Nice, France
          CHU de Nice
        Dec 5, 2022

        MDD Trial in London (MIJ821)

        Not yet recruiting
        • Major Depressive Disorder
        • London, United Kingdom
          Parexel Early Phase Clinical Unit (LONDON)
        Dec 18, 2022

        Nicotine and Brain Imaging Research Study

        Completed
        • Nicotine
          • Philadelphia, Pennsylvania
            Penn Center for Women's Behavioral Wellness, University of Penns
          Aug 3, 2021

          Spasticity, Muscle, Spinal Cord Injuries Trial in Edmonton (Baclofen)

          Withdrawn
          • Spasticity, Muscle
          • Spinal Cord Injuries
          • Edmonton, Alberta, Canada
            524 HMRC, University of Alberta
          Mar 29, 2022

          Inhibitory Neurotransmission in the Human Epileptic Brain.

          Recruiting
          • Drug Resistant Epilepsy
          • ex-vivo study
          • Pozzilli, Isernia, Italy
            IRCCS INM Neuromed
          Jul 29, 2022

          Neuroblastoma Trial in Houston (EBV specific CTLs)

          Active, not recruiting
          • Neuroblastoma
          • EBV specific CTLs
          • Houston, Texas
            Texas Children's Hospital
          Feb 2, 2022